Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11814432
Anti-HLA-A2 antibodies, related chimeric antigen receptors, and uses thereof
granted -
US 11813257
Methods of treating erythropoietic protoporphyria, X-linked protoporphyria, or congenital erythropoietic porphyria with glycine transport inhibitors
granted -
US 11814657
Modified DNase and uses thereof
granted -
US 11814376
Hepatitis b core protein modulators
granted -
US 11813485
Systems and methods for histotripsy immunosensitization
granted -
US 11814371
Heterocyclic compound
granted -
US 11814431
B7-H4 antibodies and methods of use thereof
granted -
US 11814428
Anti-PTCRA antibody-drug conjugates and uses thereof
granted -
US 11814394
Exatecan derivatives, linker-payloads, and conjugates and thereof
granted -
US 11813377
Microfiber structures and methods of synthesis and use thereof
granted -
US 11813359
Sustained release olanzapine formulations
granted -
US 11814373
Methods and compounds for restoring mutant p53 function
granted -
US 11814641
Retroviral and lentiviral vectors
granted -
US 11815516
Protein biomarkers for diseases associated with the contact activation system
granted -
US 11814645
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 11814447
Peptide ligands for binding to EphA2
granted -
US 11814445
Cyclic polypeptides for PCSK9 inhibition
granted -
US 11814444
Cyclic polypeptides for PCSK9 inhibition
granted -
US 11814440
Glypican 2 as a cancer marker and therapeutic target
granted -
US 11814622
OPA1 antisense oligomers for treatment of conditions and diseases
granted -
US 11814410
Matrix metalloproteinase substrates and other cleavable moieties and methods of use thereof
granted -
US 11814427
Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 11813123
Ultrasound responsive micro-composite markers
granted -
US 11813235
Guanfacine as an anti-virulence agent
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.